What services does D2 Laboratories offer. How does D2 Laboratories compare to competitors in the diagnostic testing industry. What are the key metrics and business models of D2 Laboratories. How has D2 Laboratories positioned itself in the healthcare and life sciences sectors.
Overview of D2 Laboratories: A Leading Diagnostic Testing Provider
D2 Laboratories, founded in 2014 and based in Tampa, Florida, has established itself as a prominent player in the diagnostic testing industry. The company offers a wide array of testing services, catering to various healthcare needs and scientific research requirements. Despite being a relatively young company, D2 Laboratories has quickly gained traction in the competitive landscape of diagnostic services.
Core Services Offered by D2 Laboratories
D2 Laboratories provides an extensive range of diagnostic testing services, including:
- Pharmacogenomic tests
- Drug abuse and alcohol tests (oral and urine)
- Infectious disease tests
- Hereditary cancer screening tests
These services position D2 Laboratories as a comprehensive solution provider in the diagnostic testing arena, addressing crucial areas of healthcare and medical research.
Market Segments and Business Models of D2 Laboratories
D2 Laboratories operates primarily in two key market segments:
- Life Sciences
- Healthcare
Within these segments, the company has adopted specific business models, though the exact details are not publicly disclosed. This strategic positioning allows D2 Laboratories to serve a diverse clientele, ranging from healthcare providers to research institutions.
How does D2 Laboratories’ market positioning impact its growth potential?
By focusing on both life sciences and healthcare segments, D2 Laboratories has created a robust foundation for sustained growth. This dual-focus approach enables the company to capitalize on advancements in both scientific research and clinical applications, potentially leading to expanded service offerings and increased market share.
Funding and Investment Landscape of D2 Laboratories
As of the latest available information, D2 Laboratories has not raised any funding rounds. The company’s current status is listed as “Unfunded,” which presents an interesting scenario in the competitive diagnostic testing market.
What are the implications of D2 Laboratories’ unfunded status?
The lack of external funding could indicate several possibilities:
- Self-sustaining business model with strong revenue generation
- Bootstrapped growth strategy focused on organic expansion
- Potential for future funding rounds to accelerate growth
This unfunded status sets D2 Laboratories apart from many of its competitors, potentially influencing its operational strategies and market approach.
Leadership and Governance at D2 Laboratories
At the helm of D2 Laboratories is Michael Heald, who serves as the Founder and CEO. Heald’s entrepreneurial background, having founded at least one other company, brings valuable experience to D2 Laboratories’ leadership.
How does Michael Heald’s leadership influence D2 Laboratories’ direction?
Michael Heald’s experience as a serial entrepreneur likely contributes to D2 Laboratories’ strategic vision and operational execution. His leadership may be instrumental in navigating the competitive landscape of the diagnostic testing industry, particularly given the company’s unfunded status.
Competitive Analysis: D2 Laboratories in the Diagnostic Testing Market
D2 Laboratories operates in a highly competitive environment, with 1,338 active competitors identified. The company currently ranks 913th among these competitors, indicating significant room for growth and market penetration.
Key Competitive Metrics
- 145 funded competitors
- 199 competitors have achieved exits
- Total funding raised across the competitive landscape: $4.71 billion
- 468 funding rounds involving 652 investors
These metrics highlight the intense competition and substantial investment interest in the diagnostic testing sector.
Who are the top competitors of D2 Laboratories?
Some notable competitors of D2 Laboratories include:
- Hologic: A public company founded in 1985, based in Bedford
- MedGenome: A Series D company founded in 2013, based in Bengaluru
- Foundation Medicine: An acquired company founded in 2010, based in Cambridge
These competitors represent a mix of established public companies, well-funded startups, and acquired entities, illustrating the diverse competitive landscape D2 Laboratories faces.
Technological Advancements and Service Expansion Opportunities
In the rapidly evolving field of diagnostic testing, technological advancements play a crucial role in determining a company’s success. D2 Laboratories, with its focus on cutting-edge tests like pharmacogenomics and hereditary cancer screening, is well-positioned to leverage emerging technologies.
What potential areas of expansion exist for D2 Laboratories?
Given the company’s existing expertise, potential areas for service expansion could include:
- Advanced molecular diagnostics
- Personalized medicine applications
- AI-driven diagnostic tools
- Point-of-care testing solutions
- Genomic profiling services
By exploring these areas, D2 Laboratories could strengthen its market position and differentiate itself from competitors.
Challenges and Opportunities in the Diagnostic Testing Industry
The diagnostic testing industry faces several challenges and opportunities that could significantly impact D2 Laboratories’ future growth and success.
What are the key challenges facing D2 Laboratories and the industry as a whole?
Some of the primary challenges include:
- Regulatory compliance and changing healthcare policies
- Reimbursement pressures from insurance providers
- Rapid technological advancements requiring continuous investment
- Data security and patient privacy concerns
- Increasing competition from both established players and innovative startups
What opportunities can D2 Laboratories capitalize on?
Despite these challenges, several opportunities exist:
- Growing demand for personalized medicine and targeted therapies
- Increasing focus on preventive healthcare and early disease detection
- Expansion into emerging markets with growing healthcare needs
- Partnerships with pharmaceutical companies for companion diagnostics
- Integration of artificial intelligence and machine learning in diagnostic processes
By addressing these challenges and leveraging opportunities, D2 Laboratories can strengthen its market position and drive future growth.
Future Outlook and Potential Growth Strategies for D2 Laboratories
As D2 Laboratories continues to navigate the competitive landscape of diagnostic testing, several potential growth strategies could propel the company forward.
What strategic initiatives could D2 Laboratories pursue to enhance its market position?
Some potential growth strategies include:
- Expanding service offerings through research and development
- Forming strategic partnerships with healthcare providers and research institutions
- Investing in cutting-edge technologies to improve testing accuracy and efficiency
- Exploring international expansion opportunities
- Considering mergers or acquisitions to gain market share or technological capabilities
These strategies could help D2 Laboratories solidify its position in the industry and drive long-term growth.
How might D2 Laboratories’ unfunded status influence its future growth plans?
D2 Laboratories’ current unfunded status presents both challenges and opportunities:
- Challenge: Limited financial resources for rapid expansion or large-scale investments
- Opportunity: Greater operational flexibility and independence in decision-making
- Challenge: Potential difficulty in competing with well-funded rivals
- Opportunity: Focused approach to growth, potentially leading to more sustainable expansion
By carefully navigating these factors, D2 Laboratories can chart a unique growth path in the competitive diagnostic testing landscape.
D2 Laboratories – Company Profile
Most viewed in 2019
OverviewFounders & Board of DirectorsCompetitors
D2 Laboratories Key Metrics
Company profile of D2 Laboratories
What does D2 Laboratories do?
D2 Laboratories provides a wide range of diagnostic testing services. The laboratory offers pharmacogenomic tests, drug abuse/alcohol tests (oral & urine), infectious disease test, hereditary cancer screening tests.
What sectors and market segments does D2 Laboratories operate in?
D2 Laboratories serves in the Life Sciences, Healthcare market segments.
The primary business models of D2 Laboratories are:
Life Sciences > ********* ** **** ** > ******Healthcare > ********* ** **** ** > ******
Funding and Investors of D2 Laboratories
How much funding has D2 Laboratories raised till date?
- D2 Laboratories has not raised any funding rounds yet.
Founders and Board of Directors of D2 Laboratories
Founder? Claim Profile
Who are the CEO, Founders and Directors of D2 Laboratories?
- Michael Heald, Founder & CEO, is a founder of 1 company.
View details of D2 Laboratories’s Founder profiles and Board Members
Competitors of D2 Laboratories
Competitive landscape of D2 Laboratories
- D2 Laboratories has 1338 active competitors and it ranks 913th among them.
- 145 of its competitors are funded while 199 have exited.
- Overall, D2 Laboratories and its competitors have raised over $4.71B in funding across 468 funding rounds involving 652 investors.
- There are no private Unicorns in the entire competition set.
Which are the top competitors of D2 Laboratories?
- Hologic – Bedford based, 1985 founded, Public company
- MedGenome – Bengaluru based, 2013 founded, Series D company
- Foundation Medicine – Cambridge based, 2010 founded, Acquired company
View details and comparison of D2 Laboratories’s Competitors
Frequently asked questions about D2 Laboratories
When was D2 Laboratories founded?
D2 Laboratories was founded in 2014
Where is D2 Laboratories located?
D2 Laboratories is located in Tampa, United States.
Is D2 Laboratories a public company?
D2 Laboratories is not a Public company. Its current company stage is Unfunded
View complete company profile of D2 Laboratories
Find what suits youSee pricing plans
Start using Tracxn for freeSign up now
Founder of this company?Claim this profile
Have other questions?Get in touch
Explore our recently updated companies
- GymsNearYou – Westford based, 2017 founded, Deadpooled company
- NiSa team – Tehran based, 2014 founded, Unfunded company
- UDDIN CONSULTANCY – Canada based, 2002 founded, Unfunded company
- Lemongrass House – Phuket based, 1996 founded, Unfunded company
- Vulnology – Milan based, 2013 founded, Deadpooled company
- Springform Technologies – Mumbai based, 1979 founded, Public company
Dermatopathology Lab | USF Health
USF Health Diagnostic Laboratory is where tomorrow’s pathologists, dermatologists and dermatopathologists are being trained.
That means your specimens are being read by the best of the best. It also means you gain access to the most current diagnostic pathology technology and expertise available, an advantage few other laboratories can offer.
The USF Health Diagnostic Laboratory is a team of
pathologists specially trained to read every detail in tissue and organ
specimens for a full range of maladies. Housed in a new state-of-the art
laboratory, the team includes experts in dermatopathology, occularpathology,
oncologic pathology, and nephropathology.
The USF Health Diagnostic Laboratory is geared for fast expert specimen readings with daily courier service throughout the region – from The Villages near Ocala to Sarasota to Orlando.
Services
Our expertise across multiple specialties using our new
state-of-the-art facilities means you now have access to the most advanced pathology
services available in the region. Clinical care, basic science research,
veterinary care, and county and state medical examination are some of the many
fields that tap into our expertise.
With our labs run 24/7, offering you a full range of services including:
- Board certified Pathologists and Dermatopathologists
- Specimen preparation and interpretation
- Expertise in melanoma and pigmented lesions
- Immunofluorescence and immunoperoxidase diagnostics
- System to view your order status and your patient’s reports online 24/7
- Daily specimen pickup throughout Florida
- Free courier
24-hour turnaround for routine specimens - Slide preparation for reading elsewhere
- Web-based status and reporting, as well as hard copy
Additional details about our services
To create an account, click on the New Doctor Form link below. Fill out the form and email it to the email address at the top of the form.
- New Doctor Form
- Submit a Question
Standard
Hematoxylin and Eosin (H&E)
Special Stains
AB/PAS
AFB
Alcian Blue pH 2.
5
Bielchowsky
Calcium Von Kossa
Colloidal Iron
Congo Red
Copper
Crystal Violet
Fite-Faraco
Fontana Masson
Giemsa
GMS
Gram
Jones Silver
LFB
Melanin Bleach
Mucin
Oil Red O
PAS
PAS with digestion
PAS/f
Perl’s for Iron
Retic
Steiner (Modified)
Trichrome
VVG
Direct Immunofluorescence (DIF)
IgA
IgG
IgM
C1q
C3
Albumin
Fibrinogen
Kappa
Lambda
Immunohistochemistry Stains
Actin, Anti-Muscle
Actin, Smooth Muscle (SMA)
AE1
AE1/AE3 + 8/18
AE3
Ber-EP4
BLC-2 Protein
Calponin
Calponin
CD -10
CD-15
CD-1a
CD-20
CD21
CD-3
CD-30
CD-31
CD-34
CD-4
CD-43
CD-45
CD-45RO
CD-5
CD-68
CD-7
CD79a
CD-8
CEA
Chromogranin
CK-07
CK-20
CK-5/6
D2-40
Desmin
E-Cadherin
EMA
F8 (Factor VIII)
Factor 13a
Helicobacter Pylori
HMB-45
Kappa Light Chain
Keratin Cocktail
Ki-67
L-26
Lambda Light Chain
LCA
Mast Cell Tryptase
Mel Pro
Melan-A
Melanoma
MiTF
Mycobacterium Tuberculosis
NSE
p53
P-63
Pan Mel / Ki
Pan Melanoma Cocktail
PHh4
prostrate triple stain
S-100
SMA (Actin, Smooth Muscle)
Spirochete
Synaptophysin
TTF
UCHL-1
Vimentin
Located at the USF Health Morsani Center for Advanced Healthcare.
